-
1
Figure S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
2
Table S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
3
Table S6 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
4
Table S2 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
5
Figure S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
6
Figure S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
7
Table S4 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
8
Figure S1 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
9
Table S3 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"
-
10
Table S5 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
منشور في 2025مؤلفون آخرون: "…Mahesh Saqcena (15054313)…"